« MALIGNANT AND THERAPEUTIC STEM CELLS MODELS » 

Our missions 

  •  Discovering disease biomarkers and novel targets using next-generation cancer stem cell models based on adult and induced pluripotent stem cells (iPSC).
  •  Developing adult and iPSC-derived cell therapies in immuno-oncology and regenerative medicine.
  • Coordination of INGESTEM, the National Research Infrastructure dedicated to Pluripotent Stem cells, cell reprogramming and tissue engineering.